Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen Van Schependom

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Multiple Sclerosis and Related Disorders|November 17, 2017
Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation studyLars Costers, Jeroen Gielen, Piet L Eelen, et al.
Frontiers in Digital Health|March 30, 2026
Real-world federated learning for brain imaging scientistsStijn Denissen, Jorne Laton, Matthias Grothe, et al.
Journal of Alzheimer'S Disease : JAD|November 7, 2022
Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot StudyJorne Laton, Jeroen Van Schependom, Joery Goossens, et al.
European Journal of Neurology|June 23, 2022
Brain age as a surrogate marker for cognitive performance in multiple sclerosisStijn Denissen, Denis Alexander Engemann, Alexander De Cock, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar DegenerationJoery Goossens, Jorne Laton, Jeroen Van Schependom, et al.
Scientific Reports|September 22, 2023
A cross-sectional case-control study on the structural connectome in recovered hospitalized COVID-19 patientsElke Lathouwers, Ahmed Radwan, Jeroen Blommaert, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Multiple Sclerosis and Related Disorders|November 17, 2017
Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation studyLars Costers, Jeroen Gielen, Piet L Eelen, et al.
Frontiers in Digital Health|March 30, 2026
Real-world federated learning for brain imaging scientistsStijn Denissen, Jorne Laton, Matthias Grothe, et al.
Journal of Alzheimer'S Disease : JAD|November 7, 2022
Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot StudyJorne Laton, Jeroen Van Schependom, Joery Goossens, et al.
European Journal of Neurology|June 23, 2022
Brain age as a surrogate marker for cognitive performance in multiple sclerosisStijn Denissen, Denis Alexander Engemann, Alexander De Cock, et al.
Journal of Alzheimer'S Disease : JAD|September 17, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar DegenerationJoery Goossens, Jorne Laton, Jeroen Van Schependom, et al.
Scientific Reports|September 22, 2023
A cross-sectional case-control study on the structural connectome in recovered hospitalized COVID-19 patientsElke Lathouwers, Ahmed Radwan, Jeroen Blommaert, et al.
Pageof 6